Multiple Myeloma Survival With Stem Cell Transplant

A stem cell transplant replaces unhealthy blood cells with healthy ones.

Multiple myeloma survival with stem cell transplant.

Older patients and those with low risk disease show the greatest gains over time while people with high risk factors showed the least change its researchers said. Then the patient receives new healthy blood forming stem cells. The standard of care for fit multiple myeloma patients is to receive high dose chemotherapy hdt with autologous stem cell rescue otherwise known as autologous stem cell transplant asct after completion of induction therapy. It can be a strong weapon in your fight against multiple myeloma.

Autologous stem cell transplant can provide significant remission that is both long and deep extending survival. Stem cell transplant for multiple myeloma. When stem cell transplants were first developed the new stem cells came from bone marrow and so this was known as a bone marrow. We here analyze factors influencing survival in 865 newly diagnosed mm patien.

Impact on survival of high dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma. In allogeneic transplantation stem cells are given by a donor most commonly a brother or sister. Multiple myeloma survival rate after stem cell transplant. People who have autologous or allogeneic transplants first receive high dose chemotherapy to kill the cancer cells.

Autologous stem cell transplantation is more common for multiple myeloma but either type of transplant can be used. A population based study published correction appears in blood. In a stem cell transplant the patient gets high dose chemotherapy to kill the cells in the bone marrow. The widespread use of high dose therapy and autologous stem cell transplantation asct as well as the introduction of novel agents have significantly improved outcomes in multiple myeloma mm enabling long term survival.

The long term survival of people with multiple myeloma following autologous stem cell transplant has steadily improved since 1997 through with the introduction of new medicines a large review study reports.